HLA-DRB1 and myeloid sarcoma: Furthermore, all altered differentially methylated regions (DMRs) were in the HLA class II region, presumably affecting genes like HLA-DRB5, -DRB1, -DQB1, -DQA1, -DQB2, and other MS susceptibility loci [143].